研究・業績

業績

原著論文

英文

  • Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements
    Kuwana M, Bando M, Kawahito Y, Sato S, Suda T, Kondoh Y; CTD-ILD Delphi Collaborators.
    Expert Rev Respir Med. 2023; 17(1): 71-80.
  • Early Initiation of Plasma Exchange Therapy for Anti-MDA5+ Dermatomyositis with Refractory Rapidly Progressive Interstitial Lung Disease
    Sasaki N, Nakagome Y, Kojima A, K Shimura, Ishii A, Sugiyama M, Izumi Y, Hirano K, Kurabayashi T, Hosono Y, Yamada C, Sato S.
    Intern Med. 2023 May 24. doi: 10.2169/internalmedicine.1410-22. Online ahead of print.
  • Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry.
    Okuda R, Ogura T, Hisata S, Baba T, Kondoh Y, Suda T, Johkoh T, Iwasawa T, Tomioka H, Bando M, Azuma A, Inoue Y, Arai T, Nakamura Y, Miyamoto A, Miyazaki Y, Chiba H, Ishii H, Hamada N, Terasaki Y, Kuwahira I, Sato S, Kato S, Suzuki T, Sakamoto S, Nishioka Y, Hattori N, Hashimoto N, Morita S, Ichihara N, Miyata H, Hagiwara K, Nukiwa T, Kobayashi K.
    Respiratory Investigation 61, 2023, 95-102.
  • Multiple intra-articular injections with adipose-derived stem cells for knee osteoarthritis cause severe arthritis with anti-histone H2B antibody production.
    Hosono Y, Kuwasawa A, Toyoda E, Nihei K, Sato S, Watanabe M, Sato M.
    Regenerative Therapy 24, 2023, 1.
  • New Aspects of Clinical and Immunological Characteristics in Patients with Anti-asparaginyl tRNA synthetase (anti-KS) Autoantibody.
    Hosono Y, Ishi A, Izumi Y, Sasaki N, Nogi S, Yamada C, Sato S.
    Mod Rheumatol. 2023; 34(1): 122-128.

学会発表

国際

  • Relapse of Rapidly Progressive Interstitial Lung Disease in Patients with Anti-Melanoma Differentiation- Associated Gene 5 Autoantibody Positive Dermatomyositis.
    Sasaki N, Ohisa T, Ishii A, Sugiyama M, Ota Y, Yamada C, Sato S.
    American College of Rheumatology Convergence 2023.2023.10.
  • Pharmacokinetics and Pharmacodynamics of Methotrexate Polyglutamate in Patients with Rheumatoid Arthritis Treated with Low or High Dose-Methotrexate in Combination with Adalimumab: Results from the Miracle Trial.
    Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo C-F, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Choi I A, Park S-H, Weng M-Y, Kuwana M, Lee Y J, Ishii T, Kim J, Kameda H, Kojima T, Baek H J, Hsu P-N, Huang C-M, Cheng T-T, Sung W-Y, Tsai W-C, Taninaga T, Mori M, Miyagishi H, Sato Y, Takeuchi T, Kaneko Y.
    European Congress of Rheumatology 2023. 2023.5.

ページトップへ戻る